2018
DOI: 10.1038/s41598-018-25685-1
|View full text |Cite
|
Sign up to set email alerts
|

The amino acid selected for generating mutant TbpB antigens defective in binding transferrin can compromise the in vivo protective capacity

Abstract: Haemophilus parasuis is the causative agent of the Glässer’s disease (GD), one of the most important bacterial diseases that affect young pigs worldwide. GD prevention based on vaccination is a major concern due to the limited cross-protection conferred by the inactivated whole cell vaccines used currently. In this study, vaccines based on two mutant recombinant proteins derived from transferrin binding protein B of H. parasuis (Y167A-TbpB and W176A-TbpB) were formulated and evaluated in terms of protection ag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
29
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 21 publications
(35 citation statements)
references
References 44 publications
4
29
0
Order By: Relevance
“…The demonstration that the diversity of TbpBs was distributed into three phylogenetic clusters that were not strongly associated with the time of isolation, geographical region or even species (present in G. parasuis, Actinobacillus pleuropneumoniae and A. suis) (12) suggested that it would be possible to design a TbpB-based vaccine effective against these three porcine pathogens. The TbpB Y167A antigen was able to provide protection against strains expressing a homologous or heterologous TbpB from the same phylogenetic cluster (13) (11). These results suggest that it will be possible to generate complete protection against Glässer's disease regardless of the capsular type of this bacterium and extend the protective effect to Actinobacillus pleuropneumoniae and A. suis due to the shared distribution of variants amongst these species (12).…”
Section: Introductionmentioning
confidence: 84%
See 2 more Smart Citations
“…The demonstration that the diversity of TbpBs was distributed into three phylogenetic clusters that were not strongly associated with the time of isolation, geographical region or even species (present in G. parasuis, Actinobacillus pleuropneumoniae and A. suis) (12) suggested that it would be possible to design a TbpB-based vaccine effective against these three porcine pathogens. The TbpB Y167A antigen was able to provide protection against strains expressing a homologous or heterologous TbpB from the same phylogenetic cluster (13) (11). These results suggest that it will be possible to generate complete protection against Glässer's disease regardless of the capsular type of this bacterium and extend the protective effect to Actinobacillus pleuropneumoniae and A. suis due to the shared distribution of variants amongst these species (12).…”
Section: Introductionmentioning
confidence: 84%
“…Growth of G. parasuis was as described previously (13). An aliquot of SV7 reference strain 174, which was previously passaged in pigs, was inoculated into supplemented PPLO broth [60 mg/ml nicotinamide adenine dinucleotide (b-NAD, Sigma-Adrich, USA) and 2.5 mg/ml D-glucose (Sigma-Aldrich, USA)] and grown with shaking (250 rpm/37°C) to achieve an optical density of 0.5 at 600 nm.…”
Section: G Parasuis Strain and Growth Conditionsmentioning
confidence: 99%
See 1 more Smart Citation
“…The limit of detection is indicated by the dashed line. targeting surface receptors involved in acquiring from the host iron-binding protein transferrin (16,41). The rationale for targeting surface proteins involved in iron acquisition also underlies recent attempts to target the BauA siderophore receptor from A. baumannii (42,43).…”
Section: Discussionmentioning
confidence: 99%
“…Twenty snatch-farrowed colostrum-deprived piglets (DB Genética Suína, Brazil) selected from five different sows from a high health status herd were obtained and raised as described previously (12). At day 42, piglets were anesthetized using the following drug combination: 0.3 mg/kg of acepromazine (Syntec do Brasil, Brazil), 0.3 mg/kg of midazolam (Laboratório Teuto Brasileiro, Brazil), and 15 mg/kg of Ketamine (Ceva Santé Animale, Brazil) injected by the intramuscular route.…”
Section: Pig Experimental Infection and Clinical Evaluationmentioning
confidence: 99%